High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Muñoz-Unceta N
  • Zugazagoitia J
  • Manzano A
  • Jiménez-Aguilar E
  • Olmedo ME
  • Cacho JD
  • Oliveira J
  • Dómine M
  • Ortega-Morán L
  • Aguado C
  • Luna AM
  • Fernández L
  • Pérez J
  • Font C
  • Corral J
  • Benítez G
  • Ros S
  • Biosca M
  • Calvo V
  • Martínez J
  • Sánchez-Cánovas M
  • López R
  • Sereno M
  • Mielgo X
  • Aparisi F
  • Carmona M
  • Carrión R
  • Ponce-Aix S
  • Soares M
  • Martínez-Salas I
  • García-Morillo M
  • Blasco A
  • Muñoz AJ
  • Paz-Ares L
  • Grupo de trombosis y cáncer SEOM

Grupos

Abstract

Based on the high incidence of thromboembolic events (TEs) observed in lung adenocarcinomas with ALK translocations and taking into account the biological proximity of ROS1 and ALK, we conducted a retrospective analysis of patients with advanced lung carcinoma carrying rearrangements in ROS1 from 23 centres in Spain and one centre in Portugal.

Datos de la publicación

ISSN/ISSNe:
0959-8049, 1879-0852

EUROPEAN JOURNAL OF CANCER  ELSEVIER SCI LTD

Tipo:
Article
Páginas:
193-198
PubMed:
33166862
Factor de Impacto:
3,354 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 12

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • ALK translocation, Advanced non–small cell lung cancer (NSCLC), Albumin, ROS1 rearrangement, Recurrent thrombosis, Thromboembolic event

Campos de Estudio

Cita

Compartir